< Home < Back

Ajanta Pharma informs about substantial acquisition of shares & takeovers

Date: 14-07-2026
Ajanta Pharma has informed that it enclosed Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 14, 2026 for Ravi Agrawal, trustee Ravi Agrawal Trust.

The above information is a part of company’s filings submitted to BSE.